España
India
Italia
대한민êµ
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민êµ
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Comments
Close menu
Loading...
Pacira BioSciences
PCRX
NASDAQ
Watchlist
Leave a Comment
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$19.75
0.38
1.96%
Pre-Market: Jul 19, 4:23 PM EDT
15 minutes delayed
Get Report
Comment
Pacira BioSciences (PCRX) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Government Trades
Short Interest
Latest news for Pacira BioSciences (NASDAQ:PCRX) Stock
Pacira BioSciences Stock (NASDAQ: PCRX)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Wednesday, July 10, 2024
Pacira BioSciences Announces Centers For Medi...
Benzinga Newsdesk
Monday, July 08, 2024
This Is What Whales Are Betting On Pacira BioSciences
Benzinga Insights
Top 5 Health Care Stocks That May Explode In July
Avi Kapoor
Wednesday, July 03, 2024
This Charter Communications Analyst Turns Bearish; Here Are Top 5 Downgrades For Wednesday
Avi Kapoor
Piper Sandler Maintains Overweight on Pacira ...
Benzinga Newsdesk
Barclays Downgrades Pacira BioSciences to Equ...
Benzinga Newsdesk
Tuesday, July 02, 2024
Pacira BioSciences shares are trading lower a...
Benzinga Newsdesk
U.S. FDA Approves Generic Version Of Exparel,...
Benzinga Newsdesk
Peeling Back The Layers: Exploring Pacira BioSciences Through Analyst Insights
Benzinga Insights
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Pacira ...
Benzinga Newsdesk
Friday, May 10, 2024
Pacira BioSciences Reveals Pricing Of $250.0M...
Benzinga Newsdesk
Wednesday, May 08, 2024
HC Wainwright & Co. Reiterates Buy on Pacira ...
Benzinga Newsdesk
Barclays Maintains Overweight on Pacira BioSc...
Benzinga Newsdesk
Analyst Ratings For Pacira BioSciences
Benzinga Insights
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk
Tuesday, May 07, 2024
Pacira BioSciences Reiterates Its FY24 Financ...
Benzinga Newsdesk
Pacira BioSciences Plans $150M Share Repurcha...
Benzinga Newsdesk
Pacira BioSciences Q1 2024 Adj EPS $0.62, Inl...
Benzinga Newsdesk
Tuesday, April 09, 2024
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 6 Analysts
Benzinga Insights
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
Wednesday, March 13, 2024
Pacira Biosciences Announced That FDA Has Gra...
Benzinga Newsdesk
Thursday, March 07, 2024
JP Morgan Assumes Pacira BioSciences at Overw...
Benzinga Newsdesk
Monday, March 04, 2024
HC Wainwright & Co. Reiterates Buy on Pacira ...
Benzinga Newsdesk
Friday, March 01, 2024
Navigating 4 Analyst Ratings For Pacira BioSciences
Benzinga Insights
RBC Capital Maintains Outperform on Pacira Bi...
Benzinga Newsdesk
Needham Reiterates Buy on Pacira BioSciences,...
Benzinga Newsdesk
Thursday, February 29, 2024
Pacira BioSciences Forecasts 2024 Revenue Of ...
Benzinga Newsdesk
Pacira BioSciences Q4 Adjusted EPS $0.89 Beat...
Benzinga Newsdesk
Earnings Scheduled For February 29, 2024
Benzinga Insights
Wednesday, February 28, 2024
Preview: Pacira BioSciences's Earnings
Benzinga Insights
Thursday, February 15, 2024
Pacira Publishes Study Of EXPAREL As Sciatic ...
Benzinga Newsdesk
Monday, February 12, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Thursday, February 08, 2024
Wedbush Reiterates Outperform on Pacira BioSc...
Benzinga Newsdesk
Wednesday, February 07, 2024
Pacira BioSciences Awarded Brand Pharmaceutic...
Benzinga Newsdesk
Thursday, January 04, 2024
Pacira BioSciences Reports Preliminary 2023 T...
Benzinga Newsdesk
Thursday, December 21, 2023
Pacira BioSciences Names Paul Hastings, Lead ...
Benzinga Newsdesk
Pacira BioSciences Appoints Frank D. Lee As C...
Benzinga Newsdesk
Wednesday, December 20, 2023
A Glimpse Into The Expert Outlook On Pacira BioSciences Through 7 Analysts
Benzinga Insights
Raymond James Initiates Coverage On Pacira Bi...
Benzinga Newsdesk
Friday, November 10, 2023
Pacira Announces FDA Approval Of Expanded EXP...
Benzinga Newsdesk
Monday, November 06, 2023
HC Wainwright & Co. Maintains Buy on Pacira B...
Benzinga Newsdesk
Friday, November 03, 2023
Piper Sandler Maintains Overweight on Pacira ...
Benzinga Newsdesk
RBC Capital Maintains Outperform on Pacira Bi...
Benzinga Newsdesk
Needham Maintains Buy on Pacira BioSciences, ...
Benzinga Newsdesk
Thursday, November 02, 2023
Pacira BioSciences Lowers FY23 Net Product Sa...
Benzinga Newsdesk
Pacira BioSciences Q3 2023 Adj. EPS $0.72 Mis...
Benzinga Newsdesk
Earnings Scheduled For November 2, 2023
Benzinga Insights
Wednesday, November 01, 2023
Earnings Preview: Pacira BioSciences
Benzinga Insights
Monday, October 23, 2023
Analyst Expectations for Pacira BioSciences's Future
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch